SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-319159
Filing Date
2021-11-04
Accepted
2021-11-04 06:07:45
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d249406d10q.htm   iXBRL 10-Q 833625
2 EX-31.1 d249406dex311.htm EX-31.1 10821
3 EX-31.2 d249406dex312.htm EX-31.2 10747
4 EX-32.1 d249406dex321.htm EX-32.1 5854
  Complete submission text file 0001193125-21-319159.txt   3433610

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20210930.xsd EX-101.SCH 26074
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20210930_cal.xml EX-101.CAL 25122
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20210930_def.xml EX-101.DEF 92830
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20210930_lab.xml EX-101.LAB 232352
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20210930_pre.xml EX-101.PRE 180037
10 EXTRACTED XBRL INSTANCE DOCUMENT d249406d10q_htm.xml XML 462682
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 211377809
SIC: 2834 Pharmaceutical Preparations